Phreesia (NYSE:PHR) Trading Down 12% – Time to Sell?

Phreesia, Inc. (NYSE:PHR) shares fell 12% on Friday . The company traded as low as $18.26 and last traded at $18.48. 81,020 shares changed hands during mid-day trading, a decline of 82% from the average session volume of 445,655 shares. The stock had previously closed at $21.00.

Analyst Upgrades and Downgrades

PHR has been the topic of a number of research reports. Robert W. Baird raised their price objective on Phreesia from $31.00 to $34.00 and gave the stock an “outperform” rating in a report on Friday, September 6th. JMP Securities restated a “market outperform” rating and issued a $30.00 price target on shares of Phreesia in a report on Thursday, September 5th. DA Davidson reissued a “buy” rating and set a $32.00 target price on shares of Phreesia in a research report on Thursday, September 5th. Truist Financial boosted their price objective on shares of Phreesia from $29.00 to $31.00 and gave the stock a “buy” rating in a report on Friday, September 6th. Finally, JPMorgan Chase & Co. increased their price target on Phreesia from $27.00 to $28.00 and gave the company an “overweight” rating in a report on Monday, September 9th. One investment analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $29.42.

Phreesia Stock Down 15.7 %

The firm has a market capitalization of $1.02 billion, a P/E ratio of -10.39 and a beta of 0.94. The firm’s fifty day moving average price is $21.39 and its 200-day moving average price is $22.03. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.77 and a quick ratio of 1.77.

Phreesia (NYSE:PHR) last issued its quarterly earnings results on Wednesday, September 4th. The company reported ($0.31) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.37) by $0.06. The company had revenue of $102.12 million for the quarter, compared to analysts’ expectations of $101.76 million. Phreesia had a negative return on equity of 39.34% and a negative net margin of 25.73%. As a group, equities research analysts forecast that Phreesia, Inc. will post -1.23 earnings per share for the current year.

Insider Buying and Selling at Phreesia

In related news, SVP David Linetsky sold 1,716 shares of Phreesia stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $23.25, for a total value of $39,897.00. Following the transaction, the senior vice president now owns 203,318 shares of the company’s stock, valued at approximately $4,727,143.50. This trade represents a 0.84 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, General Counsel Allison C. Hoffman sold 14,110 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $26.03, for a total transaction of $367,283.30. Following the sale, the general counsel now directly owns 121,003 shares of the company’s stock, valued at $3,149,708.09. This represents a 10.44 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 44,107 shares of company stock valued at $1,035,226. 5.80% of the stock is owned by insiders.

Institutional Trading of Phreesia

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Champlain Investment Partners LLC bought a new position in Phreesia in the 1st quarter worth $29,941,000. Boston Partners bought a new position in Phreesia in the first quarter worth $669,000. Russell Investments Group Ltd. boosted its stake in Phreesia by 1,407.9% during the first quarter. Russell Investments Group Ltd. now owns 57,874 shares of the company’s stock worth $1,385,000 after buying an additional 54,036 shares in the last quarter. Blair William & Co. IL increased its holdings in Phreesia by 42.6% in the 1st quarter. Blair William & Co. IL now owns 752,700 shares of the company’s stock valued at $18,012,000 after buying an additional 224,950 shares during the period. Finally, Sei Investments Co. increased its holdings in Phreesia by 135.3% in the 2nd quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock valued at $3,505,000 after buying an additional 95,058 shares during the period. Institutional investors and hedge funds own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.